vs

Side-by-side financial comparison of Easterly Government Properties, Inc. (DEA) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $91.5M, roughly 1.4× Easterly Government Properties, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 16.4%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 9.6%).

Easterly Government Properties, Inc. is a U.S.-headquartered real estate investment trust focused on acquiring, developing, and managing mission-critical commercial properties primarily leased to U.S. federal government agencies. Its portfolio covers office spaces, healthcare facilities, and security-related properties, serving government clients across key domestic markets.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

DEA vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.4× larger
ZLAB
$127.1M
$91.5M
DEA
Growing faster (revenue YoY)
ZLAB
ZLAB
+0.8% gap
ZLAB
17.1%
16.4%
DEA
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
9.6%
DEA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DEA
DEA
ZLAB
ZLAB
Revenue
$91.5M
$127.1M
Net Profit
$1.4M
Gross Margin
51.0%
Operating Margin
-54.6%
Net Margin
1.5%
Revenue YoY
16.4%
17.1%
Net Profit YoY
-56.9%
EPS (diluted)
$0.36
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DEA
DEA
ZLAB
ZLAB
Q1 26
$91.5M
Q4 25
$87.0M
$127.1M
Q3 25
$86.2M
$115.4M
Q2 25
$84.2M
$109.1M
Q1 25
$78.7M
$105.7M
Q4 24
$78.3M
$108.5M
Q3 24
$74.8M
$101.8M
Q2 24
$76.2M
$100.1M
Net Profit
DEA
DEA
ZLAB
ZLAB
Q1 26
$1.4M
Q4 25
$4.6M
Q3 25
$1.2M
$-36.0M
Q2 25
$4.1M
$-40.7M
Q1 25
$3.1M
$-48.4M
Q4 24
$5.5M
Q3 24
$4.9M
$-41.7M
Q2 24
$4.6M
$-80.3M
Gross Margin
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
77.3%
51.0%
Q3 25
76.0%
59.5%
Q2 25
77.2%
60.6%
Q1 25
77.4%
63.6%
Q4 24
76.1%
61.5%
Q3 24
77.7%
64.1%
Q2 24
76.2%
64.9%
Operating Margin
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
-54.6%
Q3 25
-42.3%
Q2 25
-50.3%
Q1 25
-53.3%
Q4 24
-62.6%
Q3 24
-66.6%
Q2 24
-76.0%
Net Margin
DEA
DEA
ZLAB
ZLAB
Q1 26
1.5%
Q4 25
5.3%
Q3 25
1.4%
-31.2%
Q2 25
4.8%
-37.3%
Q1 25
4.0%
-45.8%
Q4 24
7.0%
Q3 24
6.5%
-40.9%
Q2 24
6.0%
-80.2%
EPS (diluted)
DEA
DEA
ZLAB
ZLAB
Q1 26
$0.36
Q4 25
$0.09
$-0.05
Q3 25
$0.02
$-0.03
Q2 25
$0.09
$-0.04
Q1 25
$0.07
$-0.04
Q4 24
$0.13
$-0.09
Q3 24
$0.11
$-0.04
Q2 24
$0.11
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DEA
DEA
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$2.0M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$715.5M
Total Assets
$3.4B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DEA
DEA
ZLAB
ZLAB
Q1 26
$2.0M
Q4 25
$23.4M
$689.6M
Q3 25
$4.4M
$717.2M
Q2 25
$4.7M
$732.2M
Q1 25
$8.5M
$757.3M
Q4 24
$19.4M
$779.7M
Q3 24
$31.2M
$616.1M
Q2 24
$14.8M
$630.0M
Total Debt
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
$1.7B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
$1.6B
Q3 24
$1.5B
Q2 24
$1.4B
Stockholders' Equity
DEA
DEA
ZLAB
ZLAB
Q1 26
$1.3B
Q4 25
$1.3B
$715.5M
Q3 25
$1.3B
$759.9M
Q2 25
$1.3B
$791.7M
Q1 25
$1.3B
$810.8M
Q4 24
$1.3B
$840.9M
Q3 24
$1.3B
$667.7M
Q2 24
$1.3B
$704.2M
Total Assets
DEA
DEA
ZLAB
ZLAB
Q1 26
$3.4B
Q4 25
$3.4B
$1.2B
Q3 25
$3.4B
$1.2B
Q2 25
$3.4B
$1.2B
Q1 25
$3.2B
$1.2B
Q4 24
$3.2B
$1.2B
Q3 24
$3.1B
$985.3M
Q2 24
$3.0B
$987.4M
Debt / Equity
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
1.26×
Q3 25
1.23×
Q2 25
1.29×
Q1 25
1.20×
Q4 24
1.21×
Q3 24
1.12×
Q2 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DEA
DEA
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.7%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
$259.2M
$-26.0M
Q3 25
$155.0M
$-32.0M
Q2 25
$38.1M
$-31.0M
Q1 25
$24.2M
$-61.7M
Q4 24
$162.6M
$-55.8M
Q3 24
$57.2M
$-26.8M
Q2 24
$57.0M
$-42.2M
Free Cash Flow
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
FCF Margin
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Capex Intensity
DEA
DEA
ZLAB
ZLAB
Q1 26
0.7%
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Cash Conversion
DEA
DEA
ZLAB
ZLAB
Q1 26
Q4 25
56.44×
Q3 25
127.75×
Q2 25
9.36×
Q1 25
7.73×
Q4 24
29.82×
Q3 24
11.76×
Q2 24
12.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DEA
DEA

Rental income$88.6M97%
Other$2.3M3%
Asset management income$646.0K1%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons